You need to sign in or sign up before continuing.

HER2 Testing to Manage Patients With Breast Cancer and Other Solid Tumors: Evidence Report/Technology Assessment Number 172 by U. S. Department of Heal Human Services, Agency for Healthcare Resea And Quality

HER2 Testing to Manage Patients With Breast Cancer and Other Solid Tumors: Evidence Report/Technology Assessment Number 172

U. S. Department of Heal Human Services, Agency for Healthcare Resea And Quality

364 pages • missing pub info (editions)

nonfiction health challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

The human epidermal growth factor receptor-2 (HER2) gene is amplified and the HER2 protein overexpressed in approximately 18-20 percent of breast cancer cases. Amplification or overexpression of HER2 is associated with poor prognosis. Evidence fro...

Read more

Community Reviews

Loading...

Content Warnings

Loading...